- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Tropical Medicine
Volume 2012 (2012), Article ID 518564, 6 pages
Plasma Level of IL-4 Differs in Patients Infected with Different Modern Lineages of M. tuberculosis
1Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
2Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia
3Division of Molecular Biology and Human Genetics, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, MRC Centre for Molecular and Cellular Biology, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 19063, Francie van Zijl Drive, Tygerberg 7505, South Africa
Received 24 July 2012; Accepted 22 August 2012
Academic Editor: Marcel Tanner
Copyright © 2012 Adane Mihret et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Epidemiological evidence from tuberculosis outbreaks revealed that some genotypes of M. tuberculosis are more transmissible and capable of causing disease than others. We analysed the plasma cytokine levels of pulmonary tuberculosis patients infected with different strains of M. tuberculosis to test the hypothesis that immune responses would be linked to the bacterial genotype. Spoligotyping was carried out for genotyping, and we used Luminex technology to measure 17 cytokines (EGF, fractalkine, GM-CSF, IFN-γ, IL-1, IL-10, IL-12, IL-17, IL-4, IL-7, IL-9, IP-10, MCP-1, MCP-3, MIP-1β, TNF, and VEGF) from plasma samples of tuberculosis patients. The levels of IL-12 (p40), IL-4, IL-7, and MIP-1beta were higher in patients infected with lineage 3, however, it was only IL-4 which showed statistically significant difference () between lineage 3 and lineage 4. We further grouped the lineages into families (CAS, H and T families), and we found that the plasma level of IL-4 was significantly higher in patients infected with the CAS family () in comparison with T and H families. However, there was no difference between T and H families. Therefore, the higher level of IL-4 in lineage 3 families might indicate that possible differences in the response elicited from host depend on strain lineages in the studied population.
Tuberculosis remains a significant public health problem, and it is estimated that one-third of the world’s population is infected with Mycobacterium tuberculosis, although the majority will never develop active disease . The factors that lead to the considerable variability in the outcome of M. tuberculosis infection are complex and incompletely understood. Host genetics and environmental factors such as prior exposure to nonpathogenic mycobacteria, HIV infection, advanced age, malnutrition, alcohol abuse, diabetes, and use of corticosteroids have been associated with tuberculosis disease . Moreover, as tuberculosis disease results from the interactions between host and bacteria, there is growing evidence that the genetic diversity of Mycobacterium tuberculosis may have important clinical consequences [3, 4].
The global population structure of M. tuberculosis is defined by six phylogeographical lineages: Indo-Oceanic lineage, East Asian lineage, East African Indian lineage, Euro-American lineage, West African lineage I and West African lineage II . The Indo-Oceanic lineage (lineage I), West African lineage I (lineage 5), and West African lineage II (lineage 6) are belonging to ancient lineages whereas the East Asian lineage (lineage 2), East African-Indian lineage (lineage 3) and Euro-American lineage (lineage 4) are belonging to the modern lineage . Epidemiological evidence from tuberculosis outbreaks suggested that some genotypes of M. tuberculosis are more transmissible and more capable of causing disease than others and that some genotypes of M. tuberculosis may be associated with tuberculosis affecting different organs [6, 7]. A number of studies have described the “Beijing family” to be hypervirulent with a reduced immune response leading to higher bacillary load and enhanced dissemination with rapid progression to severe disease in humans and experimental animals [8–11].
A study in Gambia showed that progression to clinical disease was significantly less in individuals exposed to the ancient lineage compared to the modern lineage , and another study in Madagascar reported significantly lower interferon-γ production by peripheral blood T cells in individuals infected with the modern lineage . Moreover, a recent study by Portevin et al. also showed that measurement of cytokines from culture supernatants harvested 24 hours after infection of human peripheral blood monocyte-derived macrophages revealed clear differences in the level of pro-inflammatory cytokines produced by a single donor in response to different strains .
In the present study, we used plasma samples from newly diagnosed pulmonary tuberculosis patients to test the hypothesis that immune response would be linked to the infecting genotype by measuring the plasma levels of different cytokines and chemokines.
2. Materials and Methods
2.1. Patient Recruitment and M. tuberculosis DNA Separation
A total of 75 HIV-negative microbiologically confirmed new smear-positive pulmonary TB patients attending Arada, T/Haimanot, Kirkos, and W-23 health centres, Addis Ababa and who were infected with one of the three major families, T, H, and CAS, were selected from the total of 192 patients. The diagnosis of TB in the health centers was based on the national guidelines of at least two positive smears for acid-fast bacilli (AFB) in three specimens collected from each patient as spot-morning-spot. All sputum samples from TB cases were cultured for mycobacteria. The presence of HIV infection was ruled out using rapid tests (Stat pack, KHP, and Unigold as a tie breaker) as per the national guideline. The modified Petroff’s method was used to digest and decontaminate the sputum specimens. An aliquot of 100 μL of the sample was then inoculated onto two Löwenstein-Jensen (LJ) slants. Bacterial growth was read every week up to 8 weeks. Cultures with no growth after the 8th week were considered negative. M. tuberculosis isolates were identified using PCR-based genotyping with previously described methods for RD9 deletions . Mycobacterial genomic DNA was extracted by heating the isolates at 80°C for 60 min and was stored at −20°C until needed for spoligotyping. The study obtained an institutional ethical clearance from AHRI/ALERT ethics committee (Reference no. p015/10) and a national ethical clearance from National Research Ethics Review Committee (NRERC) (Reference 3.10/17/10). We sought a written informed consent from all participants.
Spoligotyping was carried out using the commercially available kit from Ocimum Biosolutions, India, according to the manufacturer’s instructions. Briefly, the direct-repeat (DR) region was amplified with primers DRa (biotinylated at the 5′ end) and DRb, and the amplified DNA was hybridized to inter-DR spacer oligonucleotides covalently bound to a membrane. DNA from Mycobacterium bovis BCG and M. tuberculosis H37Rv was used as a positive control, whereas autoclaved ultrapure water was used as a negative control. The amplified DNA was subsequently hybridized to a set of 43 oligonucleotide probes by reverse line blotting. The presence of spacers was visualized on film as black squares after incubation with streptavidinperoxidase and detected with the enhanced chemoluminescence system detection liquid (Amersham, Little Chalfont, UK).
2.3. Cytokine Measurement
We used a 17plex kit (epidermal growth factor (EGF), FRACTALKINE, granulocyte macrophage colony-stimulating factor (GM CSF), IFN-γ, IL-1, IL 10, IL-12, IL-17, IL-4, IL-7, IL-9, IFN-γ-inducible protein (IP-10/CXCL-10), Macrophage chemoattractant protein 1 (MCP-1/CXCL), MCP-3, monocyte inflammatory protein 1 beta (MIP-1β), TNF, and VEGF) from Millipore, Germany, and multicytokine analysis was done using Luminex (Millipore, Germany) technology. The principle of the technique is based on developing color-coded microspheres by combining different ratios of two dyes, and this combination can give upto 100 different combinations, which enables to measure 100 analytes. The technology combines flow cytometry and ELISA together where the capture antibody is conjugated with beads or microspheres, whereas the secondary antibody is conjugated with fluorochrome which quantifies the antigen-antibody reaction by measuring the relative fluorescence intensity. The assays were performed according to the supplier instruction. Briefly, following prewetting of plates, 50 μL precombined beads of all the 17 individual cytokines or chemokines were added and washed twice. Plasma samples (25 μL) were diluted 1 : 1 with the kit serum matrix and added to the plate. The plate was shaken for 30 sec at 1000 RPM and then incubated for 1 hr on plate shaker at 300 RPM at room temperature. Plates were washed twice, and 25 μL of detection antibody was added per well and incubated for one hour on a plate shaker. Fifty microliters of a streptavidin-PE conjugate was added per well and incubated for 30 min at room temperature. Finally, plate was washed three times, and 150 microliter of sheath fluid was added to each well, and then the plate was read by Luminex machine, and data was analysed by Luminex 100 IS software version 2.3.182.
2.4. Statistical Analysis
The data were analyzed using Graphpad prism software, version 4.0. Nonparametric Mann-Whitney tests were performed to test for the significance of the observed differences in each parameter in TB and other groups. A value less than 0.05 was considered statistically significant.
3.1. Genetic Diversity and Family Assignment
A total of 75 TB patients infected with M. tuberculosis belonging to lineages 3 and lineage 4 were selected randomly from 192 patients. The lineage 3 comprises 22 CAS families, and 4 comprises 35 T and 18 H families. Among the 75 patients, 26 (34.6%) were females. The mean age was 28.7 years (range 18–64) and 31.7 years (range 18–59) for females. The representative spoligopattern is indicated in Figure 1.
3.2. Plasma Cytokine and Chemokine Levels of Patients Infected with Different M. tuberculosis Lineages
Plasma samples from 75 TB patients infected with strains belonging to lineage 3 (CAS) () and lineage 4 (H and T) () were analysed, and we compared the plasma cytokine and chemokine levels between the two lineages. The levels of IL-12 (p40), IL-4, EGF, IP 10 and MIP-1β were higher in patients infected with lineage 3; however, it was only IL-4 which was significantly different between the two lineages () (Figure 2).
3.3. Plasma Cytokine and Chemokine Level of Patients Infected with Different M. tuberculosis Families
We further grouped the lineages into different M. tuberculosis families: 22 CAS, 35 T, and 18 H families, and we found that only the level of IL 4 was significantly higher in plasma samples infected with CAS family () in comparison with H and T families. However, there was no difference between T and H families (Figure 3).
We also analysed the ratio of the main Th1 (IFN-γ and IL-12 (p40)) and Th2 (IL-4 and IL-10) hallmark cytokines, however, none of the ratios of IFN-γ/IL-4, IFN-γ/IL-10, IL-12 (p40)/IL-4, and IL-12 (p40)/IL-10 were significantly different between patients infected with the different lineages or families (Figure 4).
Understanding the effect of the genotype of the infecting organism in the pathogenesis of tuberculosis is becoming an essential question in tuberculosis research. It is well known that T-cell responses play a fundamental role during M. tuberculosis infection where a strong T-cell response leads to granuloma formation and maintenance, whereas a defective T-cell response favors progression. In the present study, we analysed the plasma level of different cytokines and chemokines in TB cases who are diseased with different M. tuberculosis genotypes common in Addis Ababa, Ethiopia.
Strains belonging to the modern lineage were the only M. tuberculosis isolates circulating in the study community, and we compared the plasma level of cytokines and chemokines of people infected with the different lineages and families within the modern lineage. Previous studies using laboratory and clinical strains have shown differences in immune response amongst M. tuberculosis isolates. For example, strain NH878 has been associated with a low inflammatory immune response and increased virulence in macrophages and animal models compared to H37Rv, H37Ra, Erdman, and CDC1551 [16–19]. A recent study also showed a wide variation in the immune response after measurement of cytokines from infected human peripheral blood monocyte-derived macrophages where modern lineages induced lower inflammatory responses in comparison with ancient lineage. This lower immune response might promote more rapid disease progression and increase transmission in case of modern lineages .
In our study, we compared the plasma level of 17 cytokines, which include proinflammatory cytokines, anti-inflammatory cytokines, angiogenic factors, and chemokines, in tuberculosis patients infected with different M. tuberculosis strains of the modern lineage. The plasma level of IL-9, IL-17, IL-7, TNF, and GM-CSF was present in very low concentrations in all patients infected with different strains. Although detectable, no significant difference in levels of EGF, fractalkine, IFN-γ, IL-1, IL-10, IL-12 (p40), IL-7, IP-10, MCP-1, MCP-3, MIP-1β, and VEGF was found between patients infected with different lineages and families. We found that only the plasma level of IL-4 was significantly higher in patients infected with lineage 3 () as compared to lineage 4. We further grouped the lineages into families, and similarly, it was IL-4 which showed statistical difference between the different families where patients infected with CAS family had a higher plasma level of IL-4 () as compared to patients infected with H and T families but there was no difference between H and T families.
Previous studies reported lower inflammatory response of modern strains including Beijing and other strains [10, 14, 20] where low inflammatory response was linked to increased virulence [8, 21]. One explanation could be that a reduction in innate immune recognition will result in a delay in engagement of the adaptive response, providing the pathogen with a significant advantage during the early stage of infection. Another study in Madagascar also showed that tuberculosis patients and their contacts who are infected with modern M. tuberculosis strains, like Beijing and Central Asian (CAS) strains, tended to induce lower IFN-γ responses than ancient strains, like East African-Indian (EAI) strains.
Although we did not compare the two broad lineages of M. tuberculosis, ancient and modern lineages, we clearly saw a marked difference in the plasma level of IL-4 within families of the modern lineage. IL-4 is an anti inflammatory cytokine, and there are hypotheses that maintenance of a prolonged Th1 response against M. tuberculosis requires not only elevation of IFN-γ, but also downmodulation of the Th2 response, specifically IL-4. IL-4 suppresses macrophage derived production of IL-12, thereby inhibiting differentiation of Th1 cells, and inhibits cell mediated immune reactions by antagonizing the macrophage-activating effect of IFN-γ. Therefore, the higher level of IL-4 in lineage 3 families might indicate that possible differences in the response elicited from host depend on strain lineages in studied population. This present study is too small and was not designed to allow the detection of clinical differences between infections with different strains, including extent of disease, presence of cavitation, and treatment response but should be investigated in future studies.
Conflict of Interests
The authors declared no conflict of interests.
The authors acknowledge the invaluable contribution to this study made by Bamlak Tessema, Sr. Semegne Tesfaye, and Sr. Etsegenet Aseffa in recruiting and following study participants. This research is part of the African European Tuberculosis Consortium (AETBC) project supported by the European and Developing Countries Clinical Trial Partnership Grant no. IP_2009_32040.
- World Health Organization, “Global tuberculosis control,” WHO Report, World Health Organization, Geneva, Switzerland, 2011.
- R. Bellamy, “Susceptibility to mycobacterial infections: the importance of host genetics,” Genes and Immunity, vol. 4, no. 1, pp. 4–11, 2003.
- M. P. Nicol and R. J. Wilkinson, “The clinical consequences of strain diversity in Mycobacterium tuberculosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 10, pp. 955–965, 2008.
- M. Coscolla and S. Gagneux, “Does M. tuberculosis genomic diversity explain disease diversity?” Drug Discovery Today, vol. 7, no. 1, pp. e43–e59, 2010.
- S. Gagneux and P. M. Small, “Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development,” The Lancet Infectious Diseases, vol. 7, no. 5, pp. 328–337, 2007.
- S. Gagneux, K. DeRiemer, T. Van et al., “Variable host-pathogen compatibility in Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2869–2873, 2006.
- A. E. Hirsh, A. G. Tsolaki, K. DeRiemer, M. W. Feldman, and P. M. Small, “Stable association between strains of Mycobacterium tuberculosis and their human host populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4871–4876, 2004.
- C. Manca, M. B. Reed, S. Freeman et al., “Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis,” Infection and Immunity, vol. 72, no. 9, pp. 5511–5514, 2004.
- M. Tanveer, Z. Hasan, A. Kanji, R. Hussain, and R. Hasan, “Reduced TNF-α and IFN-γ responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 6, pp. 581–587, 2009.
- B. López, D. Aguilar, H. Orozco, et al., “A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 30–37, 2003.
- M. Hanekom, G. D. Van Der Spuy, E. Streicher et al., “A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease,” Journal of Clinical Microbiology, vol. 45, no. 5, pp. 1483–1490, 2007.
- B. C. de Jong, P. C. Hill, A. Aiken et al., “Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 1037–1043, 2008.
- N. Rakotosamimanana, V. Raharimanga, S. F. Andriamandimby et al., “Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar,” Clinical and Vaccine Immunology, vol. 17, no. 7, pp. 1094–1103, 2010.
- D. Portevin, S. Gagneux, I. Comas, and D. Young, “Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages,” PLoS Pathogens, vol. 7, no. 3, Article ID e1001307, 2011.
- R. Brosch, S. V. Gordon, M. Marmiesse et al., “A new evolutionary scenario for the Mycobacterium tuberculosis complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3684–3689, 2002.
- C. Manca, L. Tsenova, C. E. Barry et al., “Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates,” Journal of Immunology, vol. 162, no. 11, pp. 6740–6746, 1999.
- L. Tsenova, E. Ellison, R. Harbacheuski et al., “Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli,” Journal of Infectious Diseases, vol. 192, no. 1, pp. 98–106, 2005.
- C. Manca, L. Tsenova, A. Bergtold et al., “Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 10, pp. 5752–5757, 2001.
- C. Manca, L. Tsenova, S. Freeman et al., “Hypervirulent M. tuberculosis W/Beijing strains upregulate Type I IFNs and increase expression of negative regulators of the jak-stat pathway,” Journal of Interferon and Cytokine Research, vol. 25, no. 11, pp. 694–701, 2005.
- R. Chacon-Salinas, J. Serafin-Lopez, R. Ramos-Payan, et al., “Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes,” Clinical and Experimental Immunology, vol. 140, pp. 443–449, 2005.
- S. M. Newton, R. J. Smith, K. A. Wilkinson et al., “A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 42, pp. 15594–15598, 2006.